future.bio
Business Consulting and Services • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 5416 |
| Keywords | Clinical Services, Manufacturing, Transportation, Testing, Transplantation, Organ Transplant, Xenotransplantation, Pathogen Screening, Histocompatibility, Optn |
| Founded | 2016 |
| Employees | 1-10 |
Key Contact at future.bio
Edward Gray
Founder
About future.bio
Launching the Xenotransplantation Industry!! A wide range of businesses will be needed to support the growth of xenotransplantation to bring this life saving technology to patients. This support structure is agnostic of pig genetics and the companies now competing in this space. Whoever wins this race will need this support structure the need continues as improved pig genetic designs obsolete initial products. The products and services needed are in some ways similar to that developed for transplantation of human organs, but with key differences.
future.bio revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Business Consulting and Services industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
future.bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
future.bio has never raised funding before.
future.bio Tech Stack
Discover the technologies and tools that power future.bio's digital infrastructure, from frameworks to analytics platforms.
Font scripts
Miscellaneous
JavaScript libraries
Reverse proxies
Programming languages
Security
Caching
Blogs
Databases
Miscellaneous
JavaScript libraries
United Kingdom
Israel
Saudi Arabia
Canada
Frequently asked questions
4.8
40,000 users
